Recorded Presentations from the NCCN 20th Annual Conference -- Hematologic Malignancies
The NCCN Annual Conference: Advancing the Standard of Cancer Care™ attracts more than 1,400 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other healthcare professionals involved in the care of patients with cancer. Expert faculty presents the latest cancer therapies and provides updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas. In 2015, the NCCN Annual Conference features an exciting new track session system that will allow learners to choose specific topic areas from several parallel sessions. Plenary sessions are also included.
These activities are designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
These activities are approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits may also be provided. Please refer to the complete accreditation information provided before the individual educational activity for more details.
There is no fee for these activities.
Supported by educational grants from Actelion; AstraZeneca; Bristol-Myers Squibb; BTG International; Celgene Corporation; Genentech BioOncology; Gilead Sciences, Medical Affairs; Lilly; Merck; Novartis Oncology; Pfizer; Prometheus Laboratories Inc.; and Takeda Oncology. This activity is supported by an independent educational grant from sanofi US. This activity was made possible by Pharmacyclics, Inc. and Janssen Biotech, Inc.